http://www.marketwire.com Market Wire - Pharmaceuticals and Biotech: Biotech Copyright 2006 Market Wire, Inc. All Rights Reserved. cs@marketwire.com 10 en-us http://www.marketwire.com/IMAGES/marketwire.gif http://www.marketwire.com Tue, 6 Jan 2009 00:00:00 GMT SOUTH SAN FRANCISCO, CA (MARKET WIRE) Theravance, Inc. (NASDAQ: THRX) today reported that an equity award was made to one new employee. Pursuant to Nasdaq Marketplace Rule 4350(i)(1)(A)(iv), the equity award was granted under the Theravance, Inc. 2008 New Employee Equity Incentive Plan, which the Board of Directors of Theravance adopted to facilitate the granting of equity awards to new employees. In accordance with Nasdaq rules, this grant was made under an equity incentive plan without stockholder approval. Nasdaq rules require a public announcement of equity awards to be made under this type of plan. One employee was http://www2.marketwire.com/mw/release_html_b1?release_id=463760&tsource=3 Pharmaceuticals and Biotech THRX Mon, 5 Jan 2009 17:11:00 GMT MIAMI, FL (MARKET WIRE) Sergio Gonzalez-Arias, M.D., chief of neurological surgery and medical director of Baptist Hospital's Neuroscience Center, will perform a minimally invasive lumbar discectomy on Wednesday, January 28, at 4 p.m. The webcast will be moderated by Dr. Sean Kenniff, former healthcare reporter for WFOR-CBS Channel 4. Viewers can also choose to watch the procedure in Spanish. http://www2.marketwire.com/mw/release_html_b1?release_id=463578&tsource=3 Education and Training Pharmaceuticals and Biotech Medical and Healthcare Professional Services Media and Entertainment Mon, 5 Jan 2009 16:50:00 GMT SKOKIE, IL (MARKET WIRE) NanoInk, Inc., a global leader in nanotechnology, began the new year by announcing the launch of its NanoStem Cell division. The new division will provide a highly reliable, renewable source of differentiated adult stem cells, through the application of proprietary nanopatterning, Dip Pen Nanolithography(R) technology. http://www2.marketwire.com/mw/release_html_b1?release_id=463627&tsource=3 Pharmaceuticals and Biotech Medical and Healthcare Electronics and Semiconductors Mon, 5 Jan 2009 16:36:00 GMT WINSTON-SALEM, NC (MARKET WIRE) Gastroenterologists from the Hepatobiliary and Pancreatic (HBP) Disorders Service at Wake Forest University Baptist Medical Center will perform Endoscopic Ultrasonography (EUS) and Endoscopic Retrograde Cholangiopancreatography (ERCP) during a single procedure in a live webcast at noon on Tuesday, January 15, 2009. http://www2.marketwire.com/mw/release_html_b1?release_id=463556&tsource=3 Education and Training Pharmaceuticals and Biotech Medical and Healthcare Mon, 5 Jan 2009 15:49:00 GMT MIAMI, FL (MARKET WIRE) Renato Corporation (FRANKFURT: 4OZ) is in negotiations to invest in Tissu, a company that provides regenerative and rejuvenating treatments to patients. Tissu is the only Government-permitted company in the world authorized to provide Stem Cell Treatment under license and with legal authority. The United Kingdom-based company has emerged as the brand leader in stem cell treatments. This has been achieved by providing patients with the very best of regenerative and rejuvenating treatments that modern medicine and science has to offer. Partnerships with some of the most reputable universities, http://www2.marketwire.com/mw/release_html_b1?release_id=463610&tsource=3 Pharmaceuticals and Biotech Medical and Healthcare 4OZ Mon, 5 Jan 2009 13:31:00 GMT MELBOURNE, AUSTRALIA (MARKET WIRE) Prana Biotechnology Limited (NASDAQ: PRAN) (ASX: PBT), a biopharmaceutical company focused on the research and development of treatments for neurodegenerative disorders, today announced that Rudolph E. Tanzi, Ph.D., Co-Founding Scientist of Prana, will be a panel speaker at the 2009 Goldman Sachs Healthcare CEOs Unscripted: A View From the Top Conference in New York on Thursday, January 8, 2009. http://www2.marketwire.com/mw/release_html_b1?release_id=463516&tsource=3 Pharmaceuticals and Biotech PRAN PBT Mon, 5 Jan 2009 13:30:00 GMT FOSTER CITY, CA (MARKET WIRE) SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) announced today that it has received from Defiante Farmaceutica S.A, a company controlled by Sigma-Tau Finanziaria S.p.A, a notice of intention to nominate four candidates for election to SciClone's seven-person board at the 2009 annual meeting of SciClone stockholders. The candidates include two employees of, and a consultant to, Sigma-Tau affiliates. http://www2.marketwire.com/mw/release_html_b1?release_id=463536&tsource=3 Pharmaceuticals and Biotech SCLN Mon, 5 Jan 2009 13:00:00 GMT WHEAT RIDGE, CO (MARKET WIRE) GeneThera, Inc. (PINKSHEETS: GTHR) is in discussions with a public company traded on the Nasdaq for a potential merger or acquisition. http://www2.marketwire.com/mw/release_html_b1?release_id=463486&tsource=3 Pharmaceuticals and Biotech GTHR Mon, 5 Jan 2009 13:00:00 GMT ALEXANDRIA, VA (MARKET WIRE) The American Diabetes Association, the nation's largest and leading voluntary health organization in the fight against diabetes, is pleased to announce the newest members elected to the Association's Board of Directors. http://www2.marketwire.com/mw/release_html_b1?release_id=462994&tsource=3 Pharmaceuticals and Biotech Medical and Healthcare Mon, 5 Jan 2009 12:30:00 GMT SEATTLE, WA (MARKET WIRE) Global supercomputer leader Cray Inc. (NASDAQ: CRAY) today announced it received official notification of acceptance in late 2008 from Oak Ridge National Laboratory (ORNL) and the U.S. Department of Energy for the recently installed petaflops (quadrillion mathematical calculations per second) supercomputer. This system is expected to contribute approximately $100 million in revenue to the fourth quarter of 2008. http://www2.marketwire.com/mw/release_html_b1?release_id=463495&tsource=3 Pharmaceuticals and Biotech Computers and Software CRAY Mon, 5 Jan 2009 12:00:00 GMT EWING, NJ (MARKET WIRE) DOR BioPharma, Inc. (DOR or the Company) (OTCBB: DORB) announced today that it has reached agreement with the US Food and Drug Administration (FDA) on the design of a confirmatory, pivotal Phase 3 clinical trial evaluating its lead product orBec(R) for the treatment of acute gastrointestinal Graft-versus-Host Disease (GI GVHD). The agreement was made under the FDA's Special Protocol Assessment (SPA) procedure. http://www2.marketwire.com/mw/release_html_b1?release_id=463509&tsource=3 Pharmaceuticals and Biotech DORB Mon, 5 Jan 2009 10:00:00 GMT PORTLAND, ME (MARKET WIRE) EnviroLogix Inc. (Portland, ME), a company that develops and sells rapid, on-site and lab-based immunoassays for detecting transgenic proteins in genetically modified seeds, plants and crops, and Ionian Technologies Inc. (San Diego, CA), a company commercializing a proprietary rapid nucleic acid assay technology, have concluded an Exclusive License and Technology Transfer Agreement. http://www2.marketwire.com/mw/release_html_b1?release_id=463453&tsource=3 Government Pharmaceuticals and Biotech Agriculture Food and Beverage Mon, 5 Jan 2009 10:00:00 GMT LAS VEGAS, NV (MARKET WIRE) In May of 2009, StemCell Pharma, Inc. (SCPI) will organize an international commission for the examination of Edi Leanca, a Romanian boy born blind and diagnosed with Leber's Congenital Amaurosis (LCA), the most severe form of Retinitis Pigmentosa (RP), who regained his sight after receiving stem cell implants. The technique used on Edi Leanca is a proprietary technique owned by SCPI. The examination will take place in Bucharest, Romania by a commission made up of retinal experts with representatives from Romania, the European community, Russia and the USA. A report will be issued http://www2.marketwire.com/mw/release_html_b1?release_id=463365&tsource=3 Pharmaceuticals and Biotech Medical and Healthcare Fri, 2 Jan 2009 12:30:00 GMT MONTREAL, QUEBEC (MARKET WIRE) Adaltis Inc. (TSX: ADS), an international in vitro diagnostic (IVD) company, today announced the appointment of Ms. Ellen Cheung to the position of Vice-President, Finance, reporting to Mr. Pierre Larochelle, President and Chief Executive Officer of the Company. http://www2.marketwire.com/mw/release_html_b1?release_id=463386&tsource=3 Pharmaceuticals and Biotech ADS